Status:
RECRUITING
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
Lead Sponsor:
Association Francaise d'Urologie
Conditions:
Non-Muscle-Invasive Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain represen...
Detailed Description
BACKGROUND Non-muscle infiltrating bladder tumors are a cancerous pathology with an estimated incidence of 13,000 new cases/year in France. ¾ of new cases are diagnosed at a stage where the cancer is ...
Eligibility Criteria
Inclusion Criteria:
- Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary molecular test (biomarker) prior to their resection (biopsy) diagnosis or recurrence,
- AND adult (equal to or > 18 years old),
- AND affiliated with a social security scheme in France,
- AND whose monitoring will be carried out at the recruiting center.
Exclusion Criteria:
- Patient being monitored for a non-urothelial bladder tumor
- Patient refusing follow-up
- Opposition to participation in the study
- Adult protected by law
Key Trial Info
Start Date :
February 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2033
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT05002556
Start Date
February 21 2023
End Date
December 31 2033
Last Update
April 30 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Beauvais Simone Veil
Beauvais, France
2
CHU Caen
Caen, France
3
Hôpital Privé de Sévigné
Cesson-Sévigné, France
4
Clinique des Cèdres
Cornebarrieu, France